Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Crystallography of the B-cell receptor immunoglobulin in CLL patients

Prof Paolo Ghia - San Raffaele University, Milan, Italy

Crystallography of the B-cell receptor immunoglobulin in CLL patients ( Prof Paolo Ghia - San Raffaele University, Milan, Italy )

Results of subgroup analysis of the HELIOS trial

Dr Paula Cramer – University of Cologne, Cologne, Germany

Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )

Primary results from the MABLE phase IIIb study

Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France

Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )

Results of a new phase Ib trial of voxtalisib in combination with...

Prof Farrukh Awan - Ohio State University, Columbus, USA

Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )

A laboratory model of the hypoxic tumour microenvironment

Dr Giles Best - Royal North Shore Hospital, Sydney, Australia

A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )

Will chemotherapy remain the cornerstone of CLL management?

Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany

Will chemotherapy remain the cornerstone of CLL management? ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )

Phase II study of idelalisib monotherapy in older CLL patients

Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA

Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )

Translational research and the future of CLL treatment

Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA

Translational research and the future of CLL treatment ( Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA )

Mapping the relationship between genetics and the impact of aspirin on...

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA

Mapping the relationship between genetics and the impact of aspirin on colorectal cancer ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )

Why doesn’t aspirin protect everyone from colorectal cancer?

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA

Why doesn’t aspirin protect everyone from colorectal cancer? ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )

Conference overview: Aspirin in the 21st Century

Prof Peter Rothwell – The University of Oxford, Oxford, UK

Conference overview: Aspirin in the 21st Century ( Prof Peter Rothwell – The University of Oxford, Oxford, UK )

Aspirin for cancer treatment and prevention

Prof Peter Elwood – Cardiff University, Cardiff, UK

Aspirin for cancer treatment and prevention ( Prof Peter Elwood – Cardiff University, Cardiff, UK )

More from ecancer